{"schema_version":"1","generated_at":"2026-10-28T10:24:17.972Z","data_as_of":null,"url":"https://www.findmykol.com/kol/hamid-emamekhoo","json_url":"https://www.findmykol.com/kol/hamid-emamekhoo/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"hamid-emamekhoo","name":"Hamid Emamekhoo","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Wisconsin–Madison","institution_url":"https://www.findmykol.com/institution/university-of-wisconsin-madison","city":"Madison","state":"WI","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1053602342","orcid":"0000-0002-8506-8703","openalex":"A5023616396"},"summary":"Hamid Emamekhoo is an Oncology physician affiliated with University of Wisconsin–Madison. OpenAlex indexes 248 publications with 2,899 citations (h-index 27); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":248,"cited_by_count":2899,"h_index":27,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT03600350","title":"pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"University of Wisconsin, Madison","source_url":"https://clinicaltrials.gov/study/NCT03600350","trial_url":"https://www.findmykol.com/trial/NCT03600350"}],"source":"trials"},"payments":{"company_count":10,"program_years":{"first":2021,"last":null},"rows_total":12,"shown":3,"withheld":9,"rows":[{"payer":"PFIZER INC.","program_year":2025,"amount_usd":282.46,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1053602342"},{"payer":"Sumitomo Pharma America, Inc.","program_year":2025,"amount_usd":53.69,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1053602342"},{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2024,"amount_usd":1739.98,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1053602342"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1053602342","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco-25-00007","status":"verified"},{"title":"NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025","year":2025,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2025.0018","status":"verified"},{"title":"High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes","year":2025,"journal":"Cancer Discovery","source_url":"https://doi.org/10.1158/2159-8290.cd-24-1509","status":"verified"},{"title":"Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study","year":2025,"journal":"European Urology","source_url":"https://doi.org/10.1016/j.eururo.2025.09.003","status":"verified"},{"title":"Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study","year":2024,"journal":"The Lancet Oncology","source_url":"https://doi.org/10.1016/s1470-2045(24)00211-0","status":"verified"}],"source":"works"},"contact":{"address_1":"600 HIGHLAND AVE","city":"Madison","state":"WI","zip":"537922475","phone":"608-265-1700","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1053602342","source":"identity"},"similar":[{"name":"Justine Bruce","slug":"justine-bruce","institution":"University of Wisconsin–Madison","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/justine-bruce","json_url":"https://www.findmykol.com/kol/justine-bruce/profile.json"},{"name":"Mark Albertini","slug":"mark-albertini","institution":"University of Wisconsin–Madison","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/mark-albertini","json_url":"https://www.findmykol.com/kol/mark-albertini/profile.json"},{"name":"Anne Traynor","slug":"anne-traynor","institution":"University of Wisconsin–Madison","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/anne-traynor","json_url":"https://www.findmykol.com/kol/anne-traynor/profile.json"},{"name":"Bryn Webb","slug":"bryn-webb","institution":"University of Wisconsin–Madison","specialty":"Clinical Genetics (M.D.)","url":"https://www.findmykol.com/kol/bryn-webb","json_url":"https://www.findmykol.com/kol/bryn-webb/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":9,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-01-25","provider_certified":"2021-01-25","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}